Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: Proposal for an easy strategy

28 Feb 2001

Abstract excerpt

BACKGROUND: Discrimination between late relapse of acute lymphoblastic leukemia (ALL) and secondary ALL might be clinically important, because the former might still respond favorably to chemotherapy and/or bone marrow transplantation, whereas secondary ALL is associated with poor prognosis. PROCEDURE: We present a pre-B-ALL patient in whom disease recurred 2 years after completion of treatment. Differences in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Carcinogens and Genotoxicity Assessment
Share to Chronic Myeloid Leukemia Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 11241436
DOI: 10.1002/mpo.1085

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular discrimination between relapsed and secondary acute lymphoblastic leukemia: Proposal for an easy strategyPMID 11241436Read ↗

Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at relapse of childhood precursor-B–ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual diseaseSemantic proximity Read ↗

Next-generation antigen receptor sequencing of paired diagnosis and relapse samples of B-cell acute lymphoblastic leukemia: Clonal evolution and implications for minimal residual disease target selectionSemantic proximity Read ↗

Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic cloneSemantic proximity Read ↗

Sequence analysis of clonal immunoglobulin and T-cell receptor gene rearrangements in children with acute lymphoblastic leukemia at diagnosis and at relapse: implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detectionSemantic proximity Read ↗

Relapse in children with acute lymphoblastic leukemia involving selection of a preexisting drug-resistant subcloneSemantic proximity Read ↗

Tracing relapse clone reveals complex recurrence patterns of pediatric acute lymphoblastic leukemiaSemantic proximity Read ↗

The Philadelphia Chromosome, from Negative to Positive: a Case Report of Relapsed Acute Lymphoblastic Leukemia Following Allogeneic Stem Cell TransplantationSemantic proximity Read ↗

Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition.Semantic proximity Read ↗

Leukemia relapse reconsidered from the molecular aspect.Semantic proximity Read ↗

Late Relapsing Childhood Lymphoblastic LeukemiaSemantic proximity Read ↗

<b> <i>TEL</i> </b> Deletion Analysis Supports a Novel View of Relapse in Childhood Acute Lymphoblastic LeukemiaSemantic proximity Read ↗

Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.